Endpoints News 2026年2月4日 AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira
Endpoints News 2026年2月4日 Rare pediatric PRV program reauthorized until 2029 via government funding law
Endpoints News 2026年2月4日 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News 2026年2月3日 'Turning around the Titanic': How the incoming PBM reforms will transform CMS
Endpoints News 2026年2月3日 Ultragenyx unwraps data that may be central to its gene therapy resubmission